SAN FRANCISCO , Feb. 17, 2022 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2021 on Monday, February 28, 2022, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive